在接受甲磺酸伊马替尼（STI）治疗后达到细胞遗传学完全缓解的慢性髓性白血病（CML）患者中出现Ph阴性克隆。 - Suppr | 超能文献

Emergence of Ph negative clones in chronic myeloid leukemia (CML) patients in complete cytogenetic remission after therapy with imatinib mesylate (STI).

作者信息

Gozzetti Alessandro, Tozzuoli Daniela, Crupi Rosaria, Gentili Sara, Bocchia Monica, Raspadori Donatella, Lauria Francesco

出版信息

Eur J Haematol. 2003 Oct;71(4):313-4. doi: 10.1034/j.1600-0609.2003.00148.x.

DOI:10.1034/j.1600-0609.2003.00148.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Emergence of Ph negative clones in chronic myeloid leukemia (CML) patients in complete cytogenetic remission after therapy with imatinib mesylate (STI).在接受甲磺酸伊马替尼（STI）治疗后达到细胞遗传学完全缓解的慢性髓性白血病（CML）患者中出现Ph阴性克隆。

Eur J Haematol. 2003 Oct;71(4):313-4. doi: 10.1034/j.1600-0609.2003.00148.x.

2

A novel t(6;7)(p24;q21) in a chronic myelocytic leukemia in complete cytogenetic remission after therapy with imatinib mesylate.在接受甲磺酸伊马替尼治疗后完全细胞遗传学缓解的慢性粒细胞白血病中发现一种新的t(6;7)(p24;q21)。

Cancer Genet Cytogenet. 2004 Jan 15;148(2):152-4. doi: 10.1016/s0165-4608(03)00260-7.

3

Presence of complex t(6;9;22;15) four-way chromosome rearrangement plus rare t(1;6) translocation with favorable response to imatinib therapy in chronic myelogenous leukemia.慢性粒细胞白血病中存在复杂的t(6;9;22;15)四向染色体重排以及罕见的t(1;6)易位，对伊马替尼治疗反应良好。

Leuk Lymphoma. 2011 Nov;52(11):2182-4. doi: 10.3109/10428194.2011.585674. Epub 2011 Jun 30.

4

Megakaryocyte features and bcr/abl translocation in chronic myeloid leukemia following imatinib mesylate (STI571) therapy--a fluorescence in-situ hybridization study.甲磺酸伊马替尼（STI571）治疗后慢性髓性白血病中的巨核细胞特征及bcr/abl易位——一项荧光原位杂交研究

Leuk Lymphoma. 2004 Aug;45(8):1627-31. doi: 10.1080/10428190410001683732.

5

Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic remission.甲磺酸伊马替尼诱导慢性髓性白血病患者完全细胞遗传学缓解后动员Ph染色体阴性外周血干细胞

Br J Haematol. 2003 Nov;123(3):479-83. doi: 10.1046/j.1365-2141.2003.04599.x.

6

Deletion of the der(9q) in chronic myeloid leukemia: the controversy continues.慢性髓性白血病中9号染色体衍生染色体（der(9q)）的缺失：争议仍在继续。

Leuk Lymphoma. 2009 Jun;50(6):871-2. doi: 10.1080/10428190902980889.

7

Chronic myeloid leukemia presenting with extramedullary disease as massive ascites responding to imatinib mesylate.以大量腹水为髓外病变表现的慢性髓性白血病对甲磺酸伊马替尼治疗有反应。

Leuk Lymphoma. 2005 Jul;46(7):1097-9. doi: 10.1080/10428190500096781.

8

Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate.对接受甲磺酸伊马替尼治疗的慢性粒细胞白血病（CML）患者的BCR-ABL转录本进行连续监测。

Med Oncol. 2004;21(4):349-58. doi: 10.1385/MO:21:4:349.

9

Monosomy 7 in t(9;22)-negative cells during nilotinib therapy in an imatinib-resistant chronic myeloid leukemia case.在一例对伊马替尼耐药的慢性髓性白血病患者的尼罗替尼治疗期间，t(9;22)阴性细胞中出现7号染色体单体。

Cancer Genet Cytogenet. 2007 Jul 15;176(2):169-71. doi: 10.1016/j.cancergencyto.2006.12.011.

10

Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with imatinib mesylate.在使用甲磺酸伊马替尼治疗的慢性髓性白血病完全细胞遗传学缓解期间，中枢神经系统和颈部出现源自2个不同克隆的髓外原始细胞危象。

Int J Hematol. 2005 May;81(4):307-9. doi: 10.1532/IJH97.04188.